Navigation Links
Genzyme Provides Update on Myozyme(R) Manufacturing
Date:4/21/2008

k-compensation expenses and the effect of contingent convertible debt. Genzyme reaffirmed its commitment to 20 percent compound average growth in non-GAAP earnings per share through 2011.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

This press release contains forward-looking statements regarding Genzyme's financial outlook and business plans and strategies, including without limitation: its 2008 earnings guidance; its 2008 Myozyme revenue guidance; its plans regarding the timing and content of the BLA submission for Myozyme manufactured at the 2000L scale; it expectations regarding FDA approval of that BLA and the timing thereof; its anticipated non-GAAP compound growth rate through 2011; and its belief there is no difference in the clinical effectiveness or safety of Myozyme produced at the 160L and the 2000L scales. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those fore
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
2. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
3. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
4. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
7. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
8. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
9. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
10. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
11. Genzyme Launches Cholestagel(R) in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... January 14, 2014 Carahsoft and CDS ... January 23, 2014 at 2pm EST (11am PST), “Natural ... topic focuses on how technology can turn raw, heterogeneous ... for government agencies. The online webinar will last approximately ...
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... January 13, 2014 Bob Hainsey, a ... than 20 years in the industry, has joined ... Hainsey will serve as the society’s Science and Technology ... join SPIE as our Technology Strategist, further strengthening the ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... are only one-tenth the size of a human hair, ... to the intense heat and radiation of next generation ... IV power-generating reactors are being designed to provide low-cost ... do not have. , The Department of Energy ...
... services allow Bristol-Myers Squibb to ... focus on core biopharmaceutical business, PLANO, Texas, Dec. 10 ... services contract that,calls for EDS to deliver IT infrastructure services ... allow the company to,improve productivity so Bristol-Myers Squibb can remain ...
... Importance of ... Needle-less Vaccinations, IRVING, Texas, ... Biotechnologies subsidiary of,Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) may ... greatly,expanding the use of needle-less vaccines here and abroad., ...
Cached Biology Technology:Clemson researcher studies carbon fibers for nuclear reactor safety 2EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services 2EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services 3DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program 2DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program 3
(Date:4/17/2014)... on a novel method to help kidney stone ... effective treatment possible., Kidney stones represent a major ... If left untreated, apart from being particularly painful, ... complications. In many patients treated successfully, stone recurrence ... pathological approach to diagnosis and treatment needs to ...
(Date:4/17/2014)... expression is the process whereby the genetic information ... such as proteins, which have numerous different functions ... an important intermediary during gene expression, by relating ... mechanisms involved in manufacturing proteins. , By ... molecules present in an organism at a given ...
(Date:4/17/2014)... Domestication," a special feature of The ... PNAS ) published April 29, raises a number of ... that most of us take for granted. At the ... spots around the globe shifted from hunting animals and ... , It seems so straightforward and yet the more ...
Breaking Biology News(10 mins):Rapid and accurate mRNA detection in plant tissues 2Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4
... May Control Staph Infections in Humans Including MRSA ... bacteriophage active against Staphylococcus aureus, including methicillin-resistant strains, ... their findings in the August 2007 issue of ... aureus is a highly flexible and potentially dangerous ...
... papermaking industry,s black liquor waste into synthesis gas is a ... footprint of coal-to-liquid processes, and can produce a fuel versatile ... to a team of Penn state engineers. "Black liquor is ... of fuel science. "But it has more energy value as ...
... Current Biology, a publication of Cell Press, reports some of ... that men and women differ when it comes to their ... prefer pinkor at least a redder shade of bluethan men ... were surprised at how robust they were, given the simplicity ...
Cached Biology News:Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3Coal and black liquor can produce energy from papermaking 2Girls prefer pink, or at least a redder shade of blue 2
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
... Pack provides optimized blocking and wash ... Clarifier: Ready-to-use wash solutions have been ... Coated Slides for Microarrays (Product Code ... Buffer: 1L • Microarray Post Hybridization ...
Biology Products: